Антонина Викторовна Богуш

Антонина Викторовна Богуш

Auto-generated profile, based on publicly available information

Антонина Викторовна Богуш

Specialized cardiosurgical clinical hospital named after academician B. A. Korolev

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2025 in Экспериментальная и клиническая фармакология
Verified
Journal Article
Closed access
PDF file
АДАнна Вячеславовна Дерюгина
Анна Вячеславовна Дерюгина
АБАнтонина Викторовна Богуш
Антонина Викторовна Богуш
VPVladimir V. Pichugin
Vladimir V. Pichugin
МТМария Николаевна Таламанова
Мария Николаевна Таламанова
DDDarya Andreevna Danilova
Darya Andreevna Danilova
ЮБЮрий Дмитриевич Бричкин
Юрий Дмитриевич Бричкин
Исследованы агрегация и электрофоретическая подвижность эритроцитов у пациентов при операциях на клапанах сердца при подаче молекулярного водорода (1,2 ppm) и оксида азота (40 ppm) в экстракорпоральный контур в условиях искусственного кровообращения с продолжительностью перфузии менее и более 90 мин. Использование медицинских газов вызывало снижение агрегации эритроцитов, усиливающееся в контрольной группе. Уменьшение агрегации при действии медицинских газов сопровождалось увеличением электрофоретической подвижности эритроцитов по сравнению со значениями контрольной группы, в которой данный показатель снижался. Продолжительность перфузии более 90 мин характеризовалась увеличением дезагрегирующего эффекта оксида азота и молекулярного водорода, наиболее выраженного при их сочетании, что доказывает эффективность использования медицинских газов при длительных хирургических операциях.

3 August 2020 in Grekov's Bulletin of Surgery
Verified
Journal Article
Open access
PDF file
AMA. P. Medvedev
A. P. Medvedev
SFS. A. Fedorov
S. A. Fedorov
VPVladimir V. Pichugin
Vladimir V. Pichugin
AMA. L. Maksimov
A. L. Maksimov
MSM. B. Sukhova
M. B. Sukhova
КВК. Б. Вапаев
К. Б. Вапаев
A rare case of catheter-induced infectious endocarditis of the right heart chambers complicated by embolism of the left pulmonary artery and its successful surgical treatment is presented. We performed the operation to remove a foreign body and vegetations from the superior vena cava and the right atrium, embolectomy from the left main branch of the pulmonary artery, chemical sanitation of the right chambers of the heart and pulmonary artery under extracorporeal circulation.

13 July 2025 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
VPVladimir V. Pichugin
Vladimir V. Pichugin
ADA. V. Deryugina
A. V. Deryugina
VSV. D. Selemir
V. D. Selemir
ABA. V. Bogush
A. V. Bogush
RTR. D. Trofimov
R. D. Trofimov
ЕКЕ. А. Князева
Е. А. Князева
Aim. To assess the effect of nitric oxide administered into the extracorporeal circuit and during the three-day postoperative period on oxidative stress parameters and the state of red blood cells during operations with cardiopulmonary bypass (CPB).Material and Methods. The study included 106 patients who underwent heart valve surgeries and combined interventions under CPB. Two groups of patients were created: control (53 patients); study (53 patients). Nitric oxide (40 ppm) was supplied to the oxygenator of the CPB machine and by inhalation for three days after surgery. At the stages and after the surgery, the concentration of diene (DC) and triene (TC) conjugates, Schiff bases (SB); erythrocyte catalase activity (CA) was studied; aggregation and electrophoretic mobility of erythrocytes were measured. Clinical outcomes of surgeries were studied.Results. In patients of the control group, statistically significant increase in the content of DC (by 1.2 times) and SB (by 2.0 times) was registered by the end of the surgery compared to the initial values. SB content did not return to the preoperative level even by the end of the third day after the operation. A sharp decrease in CA activity by the end of the operation (by 24.1%) and its further decrease during three postoperative days were marked. A statistically significant increase in erythrocyte aggregation was established, starting from 60 min of CB (by 18.0% higher than the initial one), reaching a maximum by the end of the operation (by 20.4% higher than the initial one) and remaining above the initial level throughout the postoperative period. The use of nitric oxide during and after the surgery made it possible to statistically significantly decrease the level of DC, TC, SB; increase the activity of erythrocyte catalase; reduce erythrocyte aggregation and increase their electrophoretic mobility both during CBP and in the postoperative period.Conclusion. Cardiopulmonary bypass stimulates the development of lipid peroxidation (LPO) processes and erythrocyte damage, which occur during surgery and continue in the immediate postoperative period. Nitric oxide, used both during cardiopulmonary bypass and during the three-day postoperative period, effectively prevents the activation of LPO processes, has an antioxidant effect, reduces erythrocyte aggregation and increases their electrophoretic mobility. The positive effect of nitric oxide is noted not only during cardiopulmonary bypass, but also during the postoperative period, which improves the clinical outcomes of heart surgery.

30 August 2025 in Innovative Medicine of Kuban
Verified
Journal Article
Open access
PDF file
ETE. V. Taranov
E. V. Taranov
VPVladimir V. Pichugin
Vladimir V. Pichugin
ABA. V. Bogush
A. V. Bogush
KNK. I. Nikitin
K. I. Nikitin
AMA. S. Malkina
A. S. Malkina
СФС. А. Федоров
С. А. Федоров
Introduction: Multiple organ dysfunction syndrome (MODS) is a common complication and leading cause of mortality in cardiac surgery patients. To date, effective therapeutic methods and preventive strategies for this condition remain undeveloped. Identification of the role of systemic inflammatory response syndrome (SIRS) as a key component in MODS pathogenesis facilitates the development of novel treatment approaches targeting the disease’s pathogenic mechanisms. The use of new pharmacological agents with anti-inflammatory properties as a part of comprehensive MODS therapy may significantly improve treatment efficacy and clinical outcomes in cardiac surgery patients.Objective: To systematize information on the pathophysiology of MODS, detailing the contribution of SIRS, as well as data on prevention and therapy methods.Materials and methods: In this study, scientific articles relevant to this topic were analyzed through searches of PubMed, Google Scholar, UpToDate, EMBASE databases. The search for relevant articles was performed using the following keywords: “multiple organ dysfunction syndrome”, “systemic inflammatory response syndrome”, “ischemia/reperfusion syndrome”, “mitochondrial failure”, “endothelial dysfunction”, “inhaled nitric oxide”, as well as their Russian equivalents. Inclusion criteria: relevance to selected review topic; alignment with one of the selected study designs (randomized clinical trials, experimental studies, and previously published literature reviews); studies related to a cohort of cardiac surgery patients. Exclusion criteria: studies focused on clinical observations or single case reports; studies with questionable data or results, as determined by analysis using established protocols (PRISMA, STROBE, SANRA, EQUATOR).Results: The following aspects were analyzed: the central role of SIRS as a key factor in the development of MODS; the pathogenesis of MODS, including ischemia-reperfusion injury, endothelial dysfunction, and microcirculatory disorders; and a shift in therapeutic focus from strategies aimed exclusively at replacing organ function to preventive approaches and targeted interventions addressing the underlying pathogenetic mechanisms.Conclusion: Understanding the key aspects of MODS pathogenesis may guide therapeutic progress, by enabling specific targeting of the pathogenetic mechanisms involved in MODS development.

31 October 2026 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
ETE. V. Taranov
E. V. Taranov
VPVladimir V. Pichugin
Vladimir V. Pichugin
ABA. V. Bogush
A. V. Bogush
KNK. I. Nikitin
K. I. Nikitin
AMA. S. Malkina
A. S. Malkina
INTRODUCTION: Hyperlactatemia after cardiac surgery with cardiopulmonary bypass (CPB) occurs in 20–40 % of patients and is associated with adverse outcomes. However, distinguishing hypoperfusion from metabolic hyperlactatemia remains difficult because simple routine diagnostic criteria are lacking. OBJECTIVE: To identify clinical phenotypes of postoperative hyperlactatemia, develop routine diagnostic criteria, and assess their association with escalation of inotropic and/or vasopressor support and clinical outcomes. MATERIALS AND METHODS: In this prospective cohort (January–December 2025), 221 of 733 adults undergoing cardiac surgery with CPB developed hyperlactatemia (arterial lactate ≥ 3.0 mmol/L within 6 h); after 41 exclusions, 180 were analyzed. Central venous oxygen saturation (ScvO2), the venous-to-arterial carbon dioxide partial pressure difference (Pv-aCO2), and lactate clearance were assessed. Hyperlactatemia was classified as ischemic or metabolic. Oxygen delivery index (DO2I) was measured in 126 patients. Receiver operating characteristic (ROC) analysis, multivariable logistic regression, and decision curve analysis (DCA) were performed. RESULTS: Hyperlactatemia occurred in 30.2 % of patients; 180 were analyzed. The ischemic phenotype was identified in 92 (51.1 %) patients and the metabolic phenotype in 88 (48.9 %). The ischemic phenotype was associated with higher peak lactate, lower lactate clearance, and more frequent escalation of inotropic and/or vasopressor support (all p < 0.001). In the exploratory ROC analysis, the internal discriminatory performance of a lactate threshold > 4.8 mmol/L was AUC 0.83, while the combination of lactate and ScvO2 yielded an AUC of 0.86. Independent predictors of support escalation were peak lactate, lactate clearance < 10 %, and ScvO2 < 65 %. The proposed criteria agreed with reduced DO2I (< 450 mL/min/m²; κ = 0.78; p < 0.001). Hospital mortality was higher in the ischemic group (7.6 vs 1.1 %; p = 0.03). CONCLUSIONS: Approximately half of patients with postoperative hyperlactatemia exhibited a hypoperfusion phenotype associated with worse outcomes. The combination of lactate > 4.8 mmol/L, ScvO2 < 65 %, Pv-aCO2 > 6 mmHg, and lactate clearance < 10 % may help stratify the probability of a hypoperfusion phenotype.

29 November 2025 in Innovative Medicine of Kuban
Verified
Journal Article
Open access
PDF file
ETE. V. Taranov
E. V. Taranov
VPVladimir V. Pichugin
Vladimir V. Pichugin
ABA. V. Bogush
A. V. Bogush
AMA. S. Malkina
A. S. Malkina
KNK. I. Nikitin
K. I. Nikitin
FMF. H. Mahgob
F. H. Mahgob
Objective : To determine the incidence and structure of postoperative pulmonary complications (PPCs) and to identify independent risk factors for their development in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). Materials and Methods : A retrospective single-center study included 658 patients who underwent cardiac surgery in 2024. Demographic, anamnestic, intra- and postoperative data were analyzed. Univariate and multivariate logistic regression analyses were used to identify risk factors for postoperative complications. Results : PPCs were observed in 71 (10.8%) patients. Atelectasis was the most common complication (7.9%). The incidence of PPCs among smokers was 24.5% (compared to 4.1% among non-smokers), and among obese patients – 21.8% (compared to 6.3% in patients with BMI 65 years (OR 6.14; 95% CI 3.38–11.16), CPB duration >120 min (OR 5.86; 95% CI 3.57–9.60), smoking history (OR 5.92; 95% CI 2.89– 12.15), obesity (BMI ≥30 kg/m²; OR 5.12; 95% CI 2.70–9.81), and combined surgery (OR 4.69; 95% CI 2.46–8.94). The presence of chronic obstructive pulmonary disease (OR 1.94; 95% CI 1.11–3.39) and pulmonary hypertension (OR 2,14; 95% CI 1.79–5.52) was also associated with an increased risk (all p < 0.001). Conclusions : The identified modifiable risk factors (smoking, obesity) highlight the importance of preoperative optimization. Nonmodifiable factors (age, type of surgery) define a high-risk group requiring increased attention and early prevention of PPC. The findings may contribute to the development of risk stratification algorithms in cardiac surgery practice.